Biventricular pacing in patients with advanced heart failure - Report of a clinical trial;Biventrikulär pacing ny behandlingsmetod vid hjärtsvikt: Alternativ för patienter med intraventrikulära retledningsrubbningar

Lakartidningen

Volumn 97, Issue 40, 2000, Pages 4450-4458

  Braunschweig, Frieder ^a   Gadler, Fredrik ^b   Linde, Cecilia ^b   Kjellström, Barbro ^b   Rydén, Lars ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANIMAL; ARTICLE; CAT; CLINICAL COMPETENCE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; COST BENEFIT ANALYSIS; COST OF ILLNESS; ECONOMICS; FEMALE; HEART MUSCLE CONDUCTION SYSTEM; HEART PACING; HUMAN; LENGTH OF STAY; MALE; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRE; STATISTICS; WALKING;

ADULT; AGED; ANIMALS; CARDIAC PACING, ARTIFICIAL; CATS; CLINICAL COMPETENCE; COST OF ILLNESS; COST-BENEFIT ANALYSIS; FEMALE; HEART CONDUCTION SYSTEM; HEART FAILURE, CONGESTIVE; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRES; WALKING;

EID: 0034605412     PISSN: 00237205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Eriksson H, Svardsudd K, Larsson B, Ohlson LO, Tibblin G, Welin L et al. Risk factors for heart failure in the general population: the study of men born in 1913. Eur Heart J 1989; 10(7): 647-56.
2. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med 1991; 325(5): 293-302.
3. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigators. N Engl J Med 1992; 327(10): 685-91.
4. Cleland JG, Erhardt L, Murray G, Hall AS, Ball SG. Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure. A report from the AIRE Study Investigators. Eur Heart J 1997; 18(1): 41-51.
5. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999; 353 (9169): 2001-7.
6. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999; 341(10): 709-17.
7. Andersson F, Rydén-Bergsten T. Hjärtsvikt kostar! Klok läkemedelsanvändning kan kapa antalet dyra sjukhusdagar. Läkartidningen 1998; 95(24): 2828-30.
8. Stevenson WG, Stevenson LW, Middlekauff HR, Fonarow GC, Hamilton MA, Woo MA et al. Improving survival for patients with advanced heart failure: a study of 737 consecutive patients. J Am Coll Cardiol 1995; 26(6): 1417-23.
9. Goldman S, Johnson G, Cohn JN, Cintron G, Smith R, Francis G. Mechanism of death in heart failure. The vasodilator heart failure trials. The V-HeFT VA Cooperative Studies Group. Circulation 1993; 87 (6 suppl): VI24-31.
10. Bakker P, Chin K, Sen A, de Jonge N, Klöpping C, Algra A et al. Biventricular pacing improves functional capacity in patients with end-stage congesive heart failure: Early experience. Pacing Electrophysiology 1995; 19(PtII): 1748-57.
11. Cazeau S, Ritter P, Lazarus A, Gras D, Backdach H, Mundler O et al. Multisite pacing for end-stage heart failure: early experience. Pacing Clin Electrophysiol 1996; 19(22 Pt 2): 1748-57.
12. Daubert JC, Ritter P, Le Breton H, Gras D, Leclercq C, Lazarus A et al. Permanent left ventricular pacing with transvenous leads inserted into the coronary veins. Pacing Clin Electrophysiol 1998; 21(1 Pt 2): 239-45.
13. Gras D, Mabo P, Tang T, Luttikuis O, Chatoor R, Pedersen AK et al. Multisite pacing as a supplemental treatment of congestive heart failure: preliminary results of the Medtronic Inc InSync Study. Pacing Clin Electrophysiol 1998; 21(11 Pt 2): 2249-55.
14. Gadler F, Juhlin-Dannfelt A, Linde C, Ribeiro A, Rydén L. Pacemaker vid hypertrof obstruktiv kardiomyopati. Ny effektiv behandling av hjärtsjukdom. Läkartidningen 1996; 93(41): 3566-72.
15. Cowie MR, Mosterd A, Wood DA, Deckers JW, Poole-Wilson PA, Sutton GC et al. The epidemiology of heart failure. Eur Heart J 1997; 18(2): 208-25.
16. Rydén-Bergsten T, Andersson F. The health care costs of heart failure in Sweden. J Intern Med 1999; 246(3): 275-84.
17. Auricchio A, Klein H, Tockman B, Sack S, Stellbrink C, Neuzner J et al. Transvenous biventricular pacing for heart failure: can the obstacles be overcome? Am J Cardiol 1999; 83(5B): 136-42D.
18. Auricchio A, Stellbrink C, Sack S, Block M, Vogt J, Bakker P et al. The Pacing Therapies for Congestive Heart Failure (PATH-CHF) study: rationale, design, and endpoints of a prospective randomized multicenter study. Am J Cardiol 1999; 83(5B): 130-35D.
19. Stellbrink C, Auricchio A, Diem B, Breithardt OA, Kloss M, Schondube FA et al. Potential benefit of biventricular pacing in patients with congestive heart failure and ventricular tachyarrhythmia. Am J Cardiol 1999; 83(5B): 143-50D.
20. Saxon LA, Boehmer JP, Hummel J, Kacet S, De Marco T, Naccarelli G et al. Biventricular pacing in patients with congestive heart failure: two prospective randomized trials. The VIGOR CHF and VENTAK CHF Investigators. Am J Cardiol 1999; 83(5B): 120-23D.